| Name | Title | Contact Details |
|---|
Visus Therapeutics is a clinical-stage company in pursuit of developing the world`s first presbyopia-correcting eye drop with the potential to last at least eight hours. With offices in Seattle, Washington, and Orange County, California, our lead clinical candidate is VTI-001 (BRIMOCHOL™), a once-daily eye drop designed to correct the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates.
Gnosko Bio is a medical and laboratory supply company based in Philadelphia, PA that provides real-time inventory management automation solutions for the biotech industry.
Mfused is a premium cannabis processor in Washington State, providing high quality concentrates, edibles, and topicals. Mfused provides the most technologically advanced extraction system to create pure C02 extracted THC vapor oil. A cannabis formulati...
Septodent is a Cambridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Perlan Therapeutics Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.